TheEdgeResearch
Home / Stocks / PROF

Profound Medical Corp. (PROF)

NASDAQ Healthcare Medical - Devices
$6.38 ▼ -3.19%
Market Cap
$233.7M
Sector
Healthcare
Industry
Medical - Devices
Beta
0.53
52-Wk Range
4.8-8.95
CEO
Arun Swarup Menawat
Country
CA
Currency
USD

Profound Medical Corp. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Mississauga, ON, CA. The stock last traded at $6.38, down 3.19% on the session, giving a market capitalisation of $233.7M. On trailing twelve-month figures it carries a trailing P/E of -7.00, a net margin of -136.9%. Its beta of 0.53 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-7.00
Price / Sales
10.01
Price / Book
5.54
EV / EBITDA
-6.27
Gross margin
73.8%
Operating margin
-144.2%
Net margin
-136.9%
Return on equity
—
Debt / equity
0.17
Current ratio
4.54
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
162
IPO date
2019-10-29
Headquarters
Mississauga, ON, CA
About Profound Medical Corp.

Profound Medical Corp., along with its subsidiaries, operates as a commercial-stage medical technology firm. The company specializes in creating magnetic resonance (MR) guided ablation therapies designed to address prostate conditions, uterine fibroids, and to provide palliative pain management. Its market reach extends to Canada, Germany, the United States, and Finland. The company's primary offering is the TULSA-PRO system, which is engineered to integrate with magnetic resonance imaging (MRI) scanners within hospitals and clinical treatment facilities. Additionally, Profound Medical offers Sonalleve, a versatile therapeutic platform that treats uterine fibroids, delivers palliative pain relief for bone metastases, and provides non-invasive solutions for uterine fibroid treatment. Profound Medical Corp. maintains its corporate headquarters in Mississauga, Canada.

Comparable companies

Profound Medical Corp. is most often compared with the following Healthcare names:

ARMPAVRCATXLNSRMXCTNNOXOWLTPRESTIMTLSI
More research on PROF
PROF technical analysis PROF TheEdge Score Compare against peers
Open full interactive analysis & DCF →